Last update :
29/10/2024
References   References 3019  
Type : Journal

Research teams : Marlborough - Sepracor Inc
Authors : Bonasia P, Cook C, Cheng Y et al.
Title : Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Reference : Curr Med Res Opin ; 23: 2477-2483. 2007

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
aerosolArformoterol Beta-stimulant
aerosolBudesonide Anti-inflammatory
aerosolIpratropium bromide Antimuscarinic
aerosolN-acetylcysteine Various
Stability of mixtures
Not specified 25°C Light
aerosol N-acetylcysteine Commercial Drug product Mucomyst® 800 mg/4 ml
aerosol Arformoterol Commercial Drug product Brovana® 15 µg/2 ml
0.5 Hour
Not specified 25°C Light
aerosol Arformoterol Commercial Drug product Brovana® 15 µg/2 ml
aerosol Budesonide Commercial Drug product Pulmicort® 0,25 mg/2 ml
0.5 Hour
Not specified 25°C Light
aerosol Arformoterol Commercial Drug product Brovana® 15 µg/2 ml
aerosol Budesonide Commercial Drug product Pulmicort® 0,5 mg/2 ml
0.5 Hour
Not specified 25°C Light
aerosol Arformoterol Commercial Drug product Brovana® 15 µg/2 ml
aerosol Ipratropium bromide Commercial Drug product Atrovent® 0,5 mg/2,5 ml
0.5 Hour

  Mentions Légales